Michael McCormick, the previous CEO has resigned to pursue other interests, the company said.
Most recently, Mr Lunsford served as senior vice president and president of US commercial operations at ev3, where he led the commercial operations for ev3’s domestic business. Previous to ev3, Mr Lunsford was president and CEO of Acorn Cardiovascular.
Dave Stassen, Anulex’s board member, said: “We are delighted by the addition of Rich to the Anulex team. Rich has a proven track record in the medical device industry and brings demonstrated entrepreneurial leadership to Anulex as we continue our commercial rollout.”